Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sohm Inc SHMN

SOHM, Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for various treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company has expertise in various drug delivery technologies, including solid dosage from, oral-controlled... see more

Recent & Breaking News (OTCPK:SHMN)

SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders

Accesswire 2 days ago

SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist

Accesswire August 2, 2024

SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers

Accesswire July 30, 2024

SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University

Accesswire July 25, 2024

SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor

Accesswire June 10, 2024

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024

GlobeNewswire May 22, 2024

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

GlobeNewswire April 1, 2024

SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

GlobeNewswire January 9, 2024

SOHM Announces Business Outlook for 2024

GlobeNewswire December 5, 2023

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California

GlobeNewswire November 21, 2023

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients' Brand Chewables

GlobeNewswire November 14, 2023

SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

GlobeNewswire October 10, 2023

SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors

GlobeNewswire September 26, 2023

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect

GlobeNewswire September 11, 2023

SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor

GlobeNewswire August 24, 2023

SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect

Accesswire August 8, 2023

SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents

Accesswire August 1, 2023

SOHM Inc. Announces the Closure of Finances-Funding for its Various Projects

Accesswire July 25, 2023

SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy

Accesswire April 26, 2023

SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label

Accesswire March 20, 2023